142 related articles for article (PubMed ID: 18559366)
1. Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema.
Goven D; Boutten A; Leçon-Malas V; Marchal-Sommé J; Amara N; Crestani B; Fournier M; Lesèche G; Soler P; Boczkowski J; Bonay M
Thorax; 2008 Oct; 63(10):916-24. PubMed ID: 18559366
[TBL] [Abstract][Full Text] [Related]
2. The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle.
Warnatz HJ; Schmidt D; Manke T; Piccini I; Sultan M; Borodina T; Balzereit D; Wruck W; Soldatov A; Vingron M; Lehrach H; Yaspo ML
J Biol Chem; 2011 Jul; 286(26):23521-32. PubMed ID: 21555518
[TBL] [Abstract][Full Text] [Related]
3. A distinctive alveolar macrophage activation state induced by cigarette smoking.
Woodruff PG; Koth LL; Yang YH; Rodriguez MW; Favoreto S; Dolganov GM; Paquet AC; Erle DJ
Am J Respir Crit Care Med; 2005 Dec; 172(11):1383-92. PubMed ID: 16166618
[TBL] [Abstract][Full Text] [Related]
4. Nrf2-regulated phase II enzymes are induced by chronic ambient nanoparticle exposure in young mice with age-related impairments.
Zhang H; Liu H; Davies KJ; Sioutas C; Finch CE; Morgan TE; Forman HJ
Free Radic Biol Med; 2012 May; 52(9):2038-46. PubMed ID: 22401859
[TBL] [Abstract][Full Text] [Related]
5. Sinensetin protects against periodontitis through binding to Bach1 enhancing its ubiquitination degradation and improving oxidative stress.
Yuan Z; Li J; Xiao F; Wu Y; Zhang Z; Shi J; Qian J; Wu X; Yan F
Int J Oral Sci; 2024 May; 16(1):38. PubMed ID: 38734708
[TBL] [Abstract][Full Text] [Related]
6. Role of BACH1 in multiple myeloma.
Chen Y; Zeng Z; Chen J
Hematology; 2024 Dec; 29(1):2352687. PubMed ID: 38767507
[TBL] [Abstract][Full Text] [Related]
7. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Roychoudhuri R; Hirahara K; Mousavi K; Clever D; Klebanoff CA; Bonelli M; Sciumè G; Zare H; Vahedi G; Dema B; Yu Z; Liu H; Takahashi H; Rao M; Muranski P; Crompton JG; Punkosdy G; Bedognetti D; Wang E; Hoffmann V; Rivera J; Marincola FM; Nakamura A; Sartorelli V; Kanno Y; Gattinoni L; Muto A; Igarashi K; O'Shea JJ; Restifo NP
Nature; 2013 Jun; 498(7455):506-10. PubMed ID: 23728300
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease.
Suzuki M; Betsuyaku T; Ito Y; Nagai K; Nasuhara Y; Kaga K; Kondo S; Nishimura M
Am J Respir Cell Mol Biol; 2008 Dec; 39(6):673-82. PubMed ID: 18566336
[TBL] [Abstract][Full Text] [Related]
9. Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice.
Yageta Y; Ishii Y; Morishima Y; Masuko H; Ano S; Yamadori T; Itoh K; Takeuchi K; Yamamoto M; Hizawa N
J Virol; 2011 May; 85(10):4679-90. PubMed ID: 21367886
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1.
Lignitto L; LeBoeuf SE; Homer H; Jiang S; Askenazi M; Karakousi TR; Pass HI; Bhutkar AJ; Tsirigos A; Ueberheide B; Sayin VI; Papagiannakopoulos T; Pagano M
Cell; 2019 Jul; 178(2):316-329.e18. PubMed ID: 31257023
[TBL] [Abstract][Full Text] [Related]
11. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease.
Boutten A; Goven D; Artaud-Macari E; Boczkowski J; Bonay M
Trends Mol Med; 2011 Jul; 17(7):363-71. PubMed ID: 21459041
[TBL] [Abstract][Full Text] [Related]
12. HDAC6-selective inhibitor CAY10603 ameliorates cigarette smoke-induced small airway remodeling by regulating epithelial barrier dysfunction and reversing.
Zhang Q; Yan L; Lu Y; Liu X; Yin Y; Wang Q; Gu X; Zhou X
Respir Res; 2024 Feb; 25(1):66. PubMed ID: 38317159
[TBL] [Abstract][Full Text] [Related]
13. The Role of Oxidative Stress and Antioxidants in Cardiovascular Comorbidities in COPD.
Miklós Z; Horváth I
Antioxidants (Basel); 2023 May; 12(6):. PubMed ID: 37371927
[TBL] [Abstract][Full Text] [Related]
14. NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease.
Ryan EM; Sadiku P; Coelho P; Watts ER; Zhang A; Howden AJM; Sanchez-Garcia MA; Bewley M; Cole J; McHugh BJ; Vermaelen W; Ghesquiere B; Carmeliet P; Rodriguez Blanco G; Von Kriegsheim A; Sanchez Y; Rumsey W; Callahan JF; Cooper G; Parkinson N; Baillie K; Cantrell DA; McCafferty J; Choudhury G; Singh D; Dockrell DH; Whyte MKB; Walmsley SR
Am J Respir Crit Care Med; 2023 Apr; 207(8):998-1011. PubMed ID: 36724365
[No Abstract] [Full Text] [Related]
15. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
Dailah HG
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
[TBL] [Abstract][Full Text] [Related]
16. Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis.
Wang L; He C
Front Immunol; 2022; 13():967193. PubMed ID: 36032081
[TBL] [Abstract][Full Text] [Related]
17. COPD lung studies of Nrf2 expression and the effects of Nrf2 activators.
Li J; Baker J; Higham A; Shah R; Montero-Fernandez A; Murray C; Cooper N; Lucas C; Fox C; Singh D; Lea S
Inflammopharmacology; 2022 Aug; 30(4):1431-1443. PubMed ID: 35441963
[TBL] [Abstract][Full Text] [Related]
18. Role of Nuclear Factor Erythroid 2‒Related Factor 2 in Chronic Obstructive Pulmonary Disease.
Ban WH; Rhee CK
Tuberc Respir Dis (Seoul); 2022 Jul; 85(3):221-226. PubMed ID: 35255667
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the Nrf2 Promoter Induces Ferroptosis by Inhibiting the Nrf2-GPX4 Axis in COPD.
Zhang Z; Fu C; Liu J; Sai X; Qin C; Di T; Yang Y; Wu Y; Bian T
Int J Chron Obstruct Pulmon Dis; 2021; 16():3347-3362. PubMed ID: 34934311
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
